Alleviating CYP and hERG liabilities by structure optimization of dihydrofuran-fused tricyclic benzo[d]imidazole series – Potent,selective and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-2 |
| |
摘 要: |
|
收稿时间: | 17 January 2018 |
本文献已被 ScienceDirect 等数据库收录! |
|